Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 1/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.38 |
| ▸ | CTSC | P53634 | 2/20 | 0.35 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.35 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.35 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.34 |
| ▸ | PRCP | P42785 | 1/20 | 0.34 |
| ▸ | REN | P00797 | 1/20 | 0.34 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.33 |
| ▸ | DDOST | P39656 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30242278 | 0.89 | MEN1 (0.42) | CALCRLKEAP1DPP7CTSCMAPK8 | |
| SCHEMBL29517049 | 0.89 | DPP7 (0.41) | DPP7CTSCMEN1KMT2APRCP | |
| SCHEMBL38657878 | 0.88 | CALCRL (0.43) | CALCRLKEAP1DPP7CTSCMAPK8 | |
| SCHEMBL29630716 | 0.85 | DPP7 (0.38) | KEAP1DPP7CTSCMEN1KMT2A | |
| SCHEMBL29590531 | 0.84 | MAPK8 (0.48) | CALCRLKEAP1MAPK8MAPK9MAPK10 | |
| SCHEMBL29723375 | 0.83 | DPP7 (0.40) | CALCRLKEAP1DPP7MAPK8MAPK9 | |
| SCHEMBL30353294 | 0.83 | CALCRL (0.49) | CALCRLDPP7CTSCMEN1KMT2A | |
| SCHEMBL38658785 | 0.83 | MAGI3 (0.44) | CALCRLKEAP1DPP7MAPK8MAPK9 | |
| SCHEMBL29836059 | 0.83 | CALCRL (0.46) | CALCRLKEAP1MAPK8MAPK9MAPK10 | |
| SCHEMBL30112831 | 0.83 | DPP7 (0.41) | CALCRLKEAP1DPP7CTSCMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692105-A1 | CYCLIC POLYPEPTIDE COMPOUND AND USE THEREOF | Bivision Pharmaceuticals, Inc (CN) | 2026-02-11 | — | — | EP | disclosed |
| CN-118754936-A | Cyclic polypeptide compound and application thereof | 晶核生物医药科技(南京)有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-118754938-A | Cyclic polypeptide compound and application thereof | 晶核生物医药科技(南京)有限公司 | 2024-10-11 | — | — | CN | disclosed |
| WO-2024198838-A1 | CYCLIC POLYPEPTIDE COMPOUND AND USE THEREOF | 晶核生物医药科技(南京)有限公司 | 2024-10-03 | — | — | WO | disclosed |
| WO-2024198837-A1 | CYCLIC POLYPEPTIDE COMPOUND AND USE THEREOF | 晶核生物医药科技(南京)有限公司 | 2024-10-03 | — | — | WO | disclosed |